Invests in
Min Investment:
$50,000.00Max Investment:
$150,000,000.00Target Investment:
$25,000,000.00
Skills
Education
- DC
Lists including Keith
Work Experience
2017
Venture Partner
2017
ARCH Venture Partners is a leading biotechnology and pharmaceutical venture capital firm
Co-Founder
2018
Autobahn Therapeutics is a CNS focused drug discovery and development company founded on technology from the Oregon Health & Science University
2018
Co-Founder
2018
Boundless Bio is an ecDNA focused oncology drug discovery and development company founded on technology from the Ludwig Cancer Research Institute at UCSD
2011 - 2019
Co-Founder
2011 - 2019
Abide Therapeutics was a serine hydrolase inhibitor drug discovery and development company founded on technology from the Scripps Research Institute that was acquired by Lundbeck in 2019
2008 - 2015
Co-Founder
2008 - 2015
Receptos (NASDAQ: RCPT) was a GPCR drug discovery and development company founded on technology from the Scripps Research Institute and acquired by Celgene in 2015 (now BMS)
2013 - 2015
Vice President, Corporate Development & Strategy
2013 - 2015
Esperion Therapeutics (NASDAQ: ESPR) is a cardiovascular drug development company
2007 - 2013
Vice President, Product & Business Development
2007 - 2013
Maxygen was a biotechnology discovery and product development company
2004 - 2007
Senior Director, Business Development
2004 - 2007
Acologix was a renal focused drug development company
2001 - 2004
Director, Business Development
2001 - 2004
Genteric was a gene therapy and drug delivery company
1995 - 1999
Consultant
1995 - 1999
LEK Consulting is a leading biotechnology strategy consulting organization